“Optimizing Transition to Extended Half-Life Factor Replacement Products,” is the latest educational opportunity to become available from Medscape. It is intended for hematologists, pediatricians, nurses, and other healthcare professionals who manage patients with hemophilia.
The activity is part of the online series, “Clinical Advances in Hemophilia: Management for Life,” whose purpose is to increase the knowledge, skills and competence of clinicians in providing individualized management of hemophilia.
The interactive program employs several fictitious hemophilia case studies to present learners with opportunities to answer a series of challenging clinical questions designed to test one’s knowledge. The goal is to discuss the practical aspects of integrating extended half-life (EHL) factor products into clinical practice.
Upon completion, participants will have:
- Increased knowledge regarding the integration of EHL factor products appropriately into clinical practice
- Greater competence related to
- Individualizing prophylaxis by transitioning from a standard factor replacement regimen to one incorporating an EHL product
- Managing practical issues associated with the care of specialized patient populations with hemophilia
Optimizing Transition to Extended Half-Life Factor Replacement Products
Steven W. Pipe, MD
CME/ABIM MOC/CE Released: 8/9/2017; Valid for credit through: 8/9/2018
Access this and other available educational activities by visiting Medscape.org, where registration is straightforward and free of charge. Once registered, you may access Clinical Advances in Hemophilia: Management for Life.
